GOT1 Antikörper (AA 157-167)
-
- Target Alle GOT1 Antikörper anzeigen
- GOT1 (Glutamic-Oxaloacetic Transaminase 1, Soluble (Aspartate Aminotransferase 1) (GOT1))
-
Bindungsspezifität
- AA 157-167
-
Reaktivität
- Human, Ratte
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GOT1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Goat polyclonal antibody raised against synthetic peptide of GOT1.
- Sequenz
- C-RSYRYWDAEK R
- Kreuzreaktivität
- Human, Ratte
- Produktmerkmale
- Antibody Reactive Against Synthetic Peptide.
- Immunogen
- A synthetic peptide corresponding to amino acids 157-167 of human GOT1.
- Top Product
- Discover our top product GOT1 Primärantikörper
-
-
- Applikationshinweise
-
ELISA (1:4000)
Western blot (0.01-1 μg/mL)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (2-3 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
From the liver to the brain across the blood-brain barrier." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 18, pp. 7315-6, (2007) (PubMed).
: "
-
From the liver to the brain across the blood-brain barrier." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 18, pp. 7315-6, (2007) (PubMed).
-
- Target
- GOT1 (Glutamic-Oxaloacetic Transaminase 1, Soluble (Aspartate Aminotransferase 1) (GOT1))
- Andere Bezeichnung
- GOT1 (GOT1 Produkte)
- Synonyme
- ASTQTL1 antikoerper, GIG18 antikoerper, cAspAT antikoerper, cCAT antikoerper, AST antikoerper, ISSD antikoerper, NSD antikoerper, SD antikoerper, SIALIN antikoerper, SIASD antikoerper, SLD antikoerper, xr406 antikoerper, CASPAT antikoerper, ASPARTATE AMINOTRANSFERASE antikoerper, ATAAT antikoerper, MATERNAL EFFECT EMBRYO ARREST 17 antikoerper, MEE17 antikoerper, T26C19.9 antikoerper, T26C19_9 antikoerper, aspartate aminotransferase antikoerper, aatA antikoerper, 83.t00021 antikoerper, AI789014 antikoerper, Got-1 antikoerper, Aspat antikoerper, Gaspat antikoerper, AL022787 antikoerper, FABP-pm antikoerper, Got-2 antikoerper, mAspAT antikoerper, ASPATA antikoerper, glutamic-oxaloacetic transaminase 1 antikoerper, solute carrier family 17 member 5 antikoerper, glutamic-oxaloacetic transaminase 1 homeolog antikoerper, aspartate aminotransferase antikoerper, glutamic-oxaloacetic transaminase 1, soluble antikoerper, glutamic-oxaloacetic transaminase 2 antikoerper, glutamatic-oxaloacetic transaminase 2, mitochondrial antikoerper, GOT1 antikoerper, SLC17A5 antikoerper, got1.S antikoerper, AAT antikoerper, aspC antikoerper, EHI_006080 antikoerper, AST2 antikoerper, ast2 antikoerper, got1 antikoerper, Got1 antikoerper, GOT2 antikoerper, Got2 antikoerper
- Gen-ID
- 2805
- Pathways
- Hepatitis C, Monocarboxylic Acid Catabolic Process, Methionine Biosynthetic Process
-